CLC Number:
| [1] 李剑. 我如何诊断和治疗POEMS综合征[J].中华血液学杂志,2019,40(5):368-371. LI Jian. How I diagnose and treat POEMS syndrome[J]. Chinese Journal of Hematology Hematol,2019,40(5):368-371. [2] Dispenzieri A. POEMS syndrome: 2017 Update on diagnosis,risk stratification,and management [J]. Am J Hematol, 2017, 92(8):814-829. [3] Nozza A. POEMS syndrome: an update[J]. Mediterr J Hematol Infect Dis, 2017, 9(1): e2017051. [4] Daijiro A, Chiaki N, Masahiro T, et al. Restrictive usage of monoclonal immunoglobulin λ light chain germline in POEMS syndrome[J]. Blood, 2008, 112(3): 836-839. [5] Kanai K, Sawai S, Sogawa K, et al. Markedly upregulated serum interleukin-12 as a novel biomarker in POEMS syndrome[J]. Neurology, 2012, 79(6): 575-582. [6] Warsame R, Yanamandra U, Kapoor P. POEMS syndrome: an Enigma[J]. Curr Hematol Malig Rep, 2017,12(2): 85-95. [7] Yokouchi H, Baba T, Misawa S, et al. Changes in subfoveal choroidal thickness and reduction of serum levels of vascular endothelial growth factor in patients with POEMS syndrome[J]. Br J Ophthalmol, 2016, 101(6):786-790. [8] Zhao H, Cai H, Wang C, et al. Prognostic value of serum vascular endothelial growth factor and hematological responses in patients with newly-diagnosed POEMS syndrome[J]. Blood Cancer J, 2018,8(4):37. [9] 曹欣欣,王琛,蔡昊,等. 血清血管内皮生长因子水平对POEMS综合征的诊断意义及其临床相关性研究[J]. 中华血液学杂志, 2014, 35(12): 1065- 1068. CAO Xinxin, WANG Cen, CAI Hao, et al. Diagnostic performance and clinical correlation of serum vascular endothelial growth factor l evels in patients with newly diagnosed POEMS syndrome[J]. Chinese Journal of Hematology, 2014, 35(12): 1065- 1068. [10] Wang C, Huang XF, Cai QQ, et al. Prognostic study for overall survival in patients with newly diagnosed POEMS syndrome[J]. Leukemia, 2017, 31(1): 100- 106. [11] Zhao H, Huang XF, Gao XM, et al. What is the best first-line treatment for POEMS syndrome: autologous transplantation, melphalan and dexamethasone, or lenalidomide and dexamethasone?[J]. Leukemia, 2019, 33(4): 1023-1029. |
|
